Ovarian Cancer Treatment Market Size, Share, Opportunities, COVID 19 Impact, And Trends By Diagnosis (Blood Tests, Imaging Tests, Laparoscopy, Colonoscopy, Others), By Treatment (Surgery, Radiation Therapy, Chemotherapy, Hormone Therapy, Clinical Trials), And By Geography - Forecasts From 2019 To 2024
- Published : May 2021
- Report Code : KSI061612669
- Pages : 120
The ovarian cancer treatment market is projected to grow at a CAGR of 7.02% to reach US$2.505 billion by 2024.
The ovarian cancer treatment market is expected to grow at a fast pace during the forecast period due to the growing incidence of ovarian cancer among women worldwide. According to the American Cancer Society, around 22,530 new cases of ovarian cancer will be diagnosed in 2019 and around 13,980 deaths are likely to occur in the same year. Region-wise, North America is expected to hold the highest market share owing to the highest health spending of the United States among all the developed regions. The growing number of clinical trials have improved the chances of new innovations for targeted cancer treatment, emanating the market growth during the forecast period. Growing awareness among women has further led to early diagnosis, further leading to the treatment of ovarian cancer at an early stage, when diagnosed, thus, improving the survival rate of the patients. Currently available treatments include surgery, chemotherapy, radiation therapy, and hormonal therapy.
Rising ovarian cancer incidence
Growing number of clinical trials for new innovations
Increasing health expenditure
High cost of cancer treatment
According to the Biospectrum news on 21st June 2019, the National Comprehensive Cancer Network (NCCN) Oncology Research Program (ORP) entered into a collaboration with AstraZeneca for enhancing the quality in cancer for people suffering from advanced ovarian cancer.
Predictive Oncology, previously known as Precision Therapeutics, in April 2019, announced that it has entered into a collaboration with Helomics and Viome to study the link between the gut microbiome and ovarian cancer.
Major industry players profiled as part of the report are Sotio (Member of PPF Group), Pfizer Inc., AstraZeneca, F. Hoffmann-La Roche Ltd, TESARO, Inc., Clovis Oncology, AbbVie Inc., Oasmia Pharmaceutical AB, ImmunoGen Inc., and Boehringer Ingelheim GmbH.
Ovarian Cancer Treatment Market Scope:
|Market size value in 2024||US$2.505 billion|
|Growth Rate||CAGR of 7.02% from 2018 to 2024|
|Forecast Unit (Value)||USD Billion|
|Segments covered||Diagnosis, Treatment, And Geography|
|Regions covered||North America, South America, Europe, Middle East and Africa, Asia Pacific|
|Companies covered||Sotio (Member of PPF Group), Pfizer Inc., AstraZeneca, F. Hoffmann-La Roche Ltd, TESARO, Inc., Clovis Oncology, AbbVie Inc., Oasmia Pharmaceutical AB, ImmunoGen Inc., Boehringer Ingelheim GmbH|
|Customization scope||Free report customization with purchase|
The ovarian cancer treatment market has been analyzed through the following segments:
Middle East and Africa
Frequently Asked Questions (FAQs)
Q1. What will be the ovarian cancer treatment market size by 2024?
A1. The ovarian cancer treatment market is projected to reach a total market size of US$2.505 billion by 2024.
Q2. Who are the major players in the ovarian cancer treatment market?
A2. Major industry players profiled as part of the report are Sotio (Member of PPF Group), Pfizer Inc., AstraZeneca, F. Hoffmann-La Roche Ltd, TESARO, Inc., Clovis Oncology, and among others.
Q3. What are the growth prospects for the ovarian cancer treatment market?
A3. The global ovarian cancer treatment market is projected to grow at a CAGR of 7.02% during the forecast period.
Q4. Which region holds the largest market share in the ovarian cancer treatment market?
A4. North America is expected to hold the highest share in the ovarian cancer treatment market owing to the highest health spending of the United States among all the developed regions.
Q5. What factors are anticipated to drive the ovarian cancer treatment market growth?
A5. The ovarian cancer treatment market is expected to grow at a fast pace during the forecast period due to the growing incidence of ovarian cancer among women worldwide.
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
3. KEY FINDINGS
4. MARKET DYNAMICS
4.1. Market Overview and Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5.1. By age group
4.5.2. By region
4.6. Product Pipeline
5. OVARIAN CANCER TREATMENT MARKET BY DIAGNOSIS
5.1. Blood Tests
5.2. Imaging Tests
6. OVARIAN CANCER TREATMENT MARKET BY TREATMENT
6.2. Radiation Therapy
6.4. Hormone Therapy
6.5. Clinical Trials
7. OVARIAN CANCER TREATMENT MARKET BY GEOGRAPHY
7.1. North America
7.2. South America
7.3.3. United Kingdom
7.4. Middle East and Africa
7.4.1. Saudi Arabia
7.5. Asia Pacific
7.5.3. South Korea
8. COMPETITIVE INTELLIGENCE
8.1. Competitive Benchmarking and Analysis
8.2. Recent Investments and Deals
8.3. Strategies of Key Players
9. COMPANY PROFILES
9.1. Sotio (Member of PPF Group)
9.2. Pfizer Inc.
9.4. F. Hoffmann-La Roche Ltd
9.5. TESARO, Inc.
9.6. Clovis Oncology
9.7. AbbVie Inc.
9.8. Oasmia Pharmaceutical AB
9.9. ImmunoGen Inc.
9.10. Boehringer Ingelheim GmbH
LIST OF FIGURES
LIST OF TABLES
Sotio (Member of PPF Group)
F. Hoffmann-La Roche Ltd
Oasmia Pharmaceutical AB
Boehringer Ingelheim GmbH
|Report Name||Published Month||Get Sample PDF|
|Connected Agriculture Market Size & Share: Report, 2021-2026||Sep 2021|
|Pyrometer Market Size, Share & Trends: Industry Report, 2021-2026||Jun 2021|
|Radiotherapy Market Size & Share: Industry Report, 2021-2026||Jul 2021|
|Data Center Colocation Market Size & Share: Report, 2023 - 2028||Jun 2023|
|Industrial Enzymes Market Size & Share: Report, 2022-2027||Nov 2022|